Latest News - Verbund AG
Top Corporates Hub
Verbund AG
BTIG Maintains Buy on Edwards Lifesciences, Raises Price Target to $110
30.06.2026 07:56
BTIG analyst Marie Thibault maintains Edwards Lifesciences (NYSE:EW) with a Buy and raises the price target from $100 to $110.
Edwards Lifesciences (EW) Is Up 6.2% After New TAVR Data at New York Valves Conference
30.06.2026 00:15
In late June 2026, Edwards Lifesciences presented extensive new clinical data at the New York Valves conference, reinforcing evidence across its aortic, mitral and tricuspid transcatheter valve therapies, including PROGRESS, PARTNER 3, EARLY TAVR, PASCAL and SAPIEN M3 programs. An important takeaway is how the PROGRESS trial’s baseline data on moderate aortic stenosis and long-term durability findings for SAPIEN 3 deepen understanding of earlier, less invasive treatment options for complex...
Edwards’ Structural Heart Leadership Demonstrated Through Expanding Body of Scientific Evidence at New York Valves
26.06.2026 14:15
NEW YORK, June 26, 2026--Edwards Lifesciences (NYSE: EW) today announced new data presented at New York Valves 2026, the annual conference organized by the Cardiovascular Research Foundation, which reinforce the company's leadership in advancing high-quality scientific evidence and innovating for patients. These new data – spanning aortic, mitral and tricuspid therapies – provide further understanding of the complexity of structural heart disease and the need for innovative treatment options.
CardioMech Shareholders Appoint Ramin Mousavi as Chairman of the Board
24.06.2026 10:01
Norway-based CardioMech AS, a medical device company developing a transfemoral, transseptally delivered mitral valve chordal repair technology in Fridley, MN, today announced the appointment of Ramin Mousavi as Chairman of the Board, effective immediately.
Here's How Macro Trends and Currency Headwind Restrict GMED's Growth
22.06.2026 14:28
Globus Medical faces inflation, geopolitical and currency pressures as rising costs and FX losses cloud margin flexibility and international growth.
Should You Continue to Hold EW Stock in Your Portfolio?
12.06.2026 12:31
Edwards gains from strong TMTT growth, RESILIA adoption and expanding TAVR use, but macro pressures and currency swings remain key risks.
Why Is Veracyte (VCYT) Up 18.2% Since Last Earnings Report?
04.06.2026 15:30
Veracyte (VCYT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
TD Cowen Maintains Buy on Edwards Lifesciences, Raises Price Target to $104
02.06.2026 10:53
TD Cowen analyst Joshua Jennings maintains Edwards Lifesciences (NYSE:EW) with a Buy and raises the price target from $97 to $104.
OPKO Health (OPK) Up 17.1% Since Last Earnings Report: Can It Continue?
28.05.2026 15:30
OPKO Health (OPK) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Josh Brown's 'best stocks in the market': Edwards Lifesciences
28.05.2026 12:59
Josh Brown, CEO of Ritholtz Wealth Management, joins CNBC's "Halftime Report" to detail Ritholt's new "Porterhouse" strategy. Josh also spotlights Edwards Lifesciences in his "Best Stocks in the Market."
Is Edwards Lifesciences (EW) Fairly Priced After Recent Share Price Strength?
28.05.2026 02:04
Wondering if Edwards Lifesciences at around US$86.51 is offering good value today, or if the recent share price leaves little margin for error. The stock has returned 4.3% over the last week, 3.7% over the past month, 1.4% year to date, and 12.8% over the past year, while the 3 year return sits at 2.7% and the 5 year return shows a decline of 7.4%. Recent coverage has focused on Edwards Lifesciences as a key player in medical equipment, with attention on how its products fit into long term...
Edwards Lifesciences Has Everything Investors Want Except Value
27.05.2026 10:32
Edwards Lifesciences remains a high-quality business with a wide economic moat , but the stock is still overvalued. Click here to read more on the EW stock.
VahatiCor Appoints Harry D. Rowland, Ph.D., as Chief Executive Officer
18.05.2026 06:00
SANTA CLARA, Calif., May 18, 2026--VahatiCor, Inc., a medtech company developing interventional therapies for Coronary Microvascular Dysfunction (CMD), announced today the appointment of Harry D. Rowland, Ph.D., as Chief Executive Officer.
Edwards Lifesciences' (NYSE:EW) Conservative Accounting Might Explain Soft Earnings
13.05.2026 10:24
Soft earnings didn't appear to concern Edwards Lifesciences Corporation's ( NYSE:EW ) shareholders over the last week...
Boston Scientific: Poised To Rebound With The Healthcare Sector, But When?
11.05.2026 16:30
Boston Scientific Corporation outlook: EP share loss vs PFA leadership, Watchman & neuromod growth, improving margins and low valuation. Click for more on BSX.
Edwards Lifesciences (EW) is Benefitting from Expanding Its Aortic Valve Franchise
11.05.2026 13:13
Artisan Partners, an investment management company, released its first-quarter 2026 investor letter for the “Artisan Mid Cap Fund”. A copy of the letter is available to download here. In Q1 2026, the Artisan Mid Cap Fund reported negative absolute returns but slightly outperformed the Russell Midcap® Growth Index. The market favored lower volatility and income-oriented equities, […]
Edwards names Theodora Mistras as CFO
05.05.2026 09:36
Mistras, who joins the heart valve company after two years as CFO at pharmaceutical firm Viatris, also brings investment banking experience.
Ten-Year Pivotal Data Demonstrate Long-Term Durability of Edwards Lifesciences’ Resilia Tissue
02.05.2026 15:50
CHICAGO, May 02, 2026--Edwards Lifesciences (NYSE: EW) today announced 10-year results from the COMMENCE aortic trial, reinforcing the long-term durability and sustained performance of its proprietary RESILIA tissue. The data were presented at the 106th American Association for Thoracic Surgery Annual Meeting.
Global's Undervalued Small Caps With Insider Actions For May 2026
01.05.2026 09:39
As global markets navigate a complex landscape marked by record highs in major U.S. stock indexes, driven by robust economic data and AI-linked stocks, small-cap companies are capturing investor interest amid resilient consumer demand and evolving geopolitical tensions. In this environment, identifying promising small-cap stocks involves considering factors such as strong earnings potential and strategic insider actions that align with broader market trends.
Barclays Lifts PT on Edwards Lifesciences Corporation (EW) Following Q1 Earnings
01.05.2026 08:00
Edwards Lifesciences Corporation (NYSE:EW) is one of the best medical device stocks to invest in right now. Barclays raised the price target on Edwards Lifesciences Corporation (NYSE:EW) to $110 from $104 on April 27, reaffirming an Overweight rating on the shares. The rating update came after the company’s fiscal Q1 earnings, with the firm telling […]